The DIA Annual Meeting is the event of the year for the pharmaceutical and related industries. No other industry event can rival the breadth and depth of experience that this meeting delivers. With more than 1,000 speakers from the FDA, EMEA, and other regulatory agencies, 27 content-area tracks, and nearly 400 sessions, the presentations are geared to attendees of all experience and functional levels. The DIA Annual Meeting, above all others, offers valuable professional cross-functional learning, continuing education credits, and networking experiences.

WHO SHOULD ATTEND

This program is designed for the full continuum of disciplines in the pharmaceutical and related industries to improve their understanding and skills for a variety of pharmaceutical development interest areas.

LEARNING OBJECTIVES 

• Describe the current regulatory and public policy environment pertaining to pharmaceuticals with an emphasis on the Food and Drug Administration
• Discuss the international regulations and economic factors that impact the global biopharmaceutical industry
• Recognize the challenges facing the FDA and the pharmaceutical industry in areas such as research study design and statistical methodology
• Recognize state-of-the-art clinical and statistical systems and implementations
• Recognize the written and communication skills needed to promote your career and your company's objectives
• Enhance your working relationship with colleagues, both locally and internationally
• Describe legal, advertising, and marketing issues related to providing product information
• Discuss statistics, economics, and quality-of-life science
• Enhance your knowledge of risk assessment and management in areas such as computer systems validation and drug safety and pharmacovigilance
• Discuss issues in safety reporting, data analysis, epidemiology, and regulations regarding adverse events